Boualem Sendid | Mycology | Best Paper Award

Published on by Medical Lab Scientist

Prof. Boualem Sendid | Mycology | Best Paper Award

Professor | University of Lille | France

Professor Boualem Sendid is a distinguished French scientist specializing in medical mycology and parasitology, with an illustrious career spanning more than 25 years. He currently serves as Full Professor at the University of Lille, where he also heads the Parasitology–Mycology Department and the Clinical Microbiology Institute at Lille University Hospital. As team leader of Inserm U1285/CNRS UMR 8576, his pioneering research focuses on fungal pathogenesis, glycobiology, and their clinical applications. Professor Sendid is internationally recognized for his groundbreaking work on Candida infections, Crohn’s disease, and the role of fungal-host interactions in inflammatory conditions. He has authored over 180 peer-reviewed publications, contributed to book chapters, and co-holds several patents. A dedicated educator and mentor, he has trained numerous postgraduate and doctoral students in medical microbiology. Beyond his academic achievements, he actively contributes to national and international scientific societies, shaping policies and advancing clinical diagnostics for invasive fungal diseases.

profile

Orcid

Education

Professor Boualem Sendid has pursued a comprehensive academic path dedicated to medical biology, microbiology, and mycology. He earned his Doctor of Pharmacy degree, accredited by the French Council of Pharmacists, establishing his professional foundation in biological sciences. He specialized in Medical Biology and Clinical Biology at the Faculty of Pharmacy, University of Lille, solidifying his expertise in laboratory medicine. His postgraduate studies further strengthened his focus on infectious diseases. He obtained a Master’s degree in Biological Sciences from the University of Lille, followed by a postgraduate diploma in Medical Mycology from the renowned Pasteur Institute in Paris. Professor Sendid achieved his PhD in Mycology-Parasitology from the University of Lille, which marked the beginning of his independent research career.  He received the prestigious Habilitation à Diriger des Recherches (HDR), accrediting him as a research director and cementing his role as an academic leader.

Experience

Professor Boualem Sendid has accumulated extensive professional experience through progressive leadership roles in clinical, academic, and research institutions. He has served as Professor of Parasitology–Mycology at the Faculty of Medicine, University of Lille, shaping the next generation of specialists in infectious diseases. He was appointed Head of the Clinical Microbiology Institute at Lille University Hospital, where he oversees diagnostic services and research integration. Parallel to his hospital duties, he leads Inserm U1285/CNRS UMR 8576, directing the research team on “Glycobiology in Fungal Pathogenesis & Clinical Applications.” Previously, he was a hospital practitioner in the University Hospital of Lille, providing expertise in clinical microbiology and laboratory diagnostics. His career demonstrates a strong balance between patient care, research innovation, and education. He has collaborated with industrial partners such as Bio-Rad and Bruker, contributing to the development of diagnostic tools and improving clinical outcomes worldwide.

Professional Development 

Throughout his career, Professor Boualem Sendid has consistently advanced his professional development by combining academic research, clinical practice, and leadership responsibilities. His early training in pharmacy, medical biology, and mycology provided him with a strong multidisciplinary foundation, which he later expanded through continuous engagement in translational research. By obtaining his HDR, he established himself as a qualified research director, enabling him to mentor doctoral students and lead major scientific programs. His involvement in Inserm and CNRS units reflects his commitment to high-level biomedical research, while his hospital leadership roles highlight his ability to bridge laboratory science with clinical applications. Professor Sendid has also pursued professional growth through international collaborations and industrial partnerships, facilitating the development of innovative fungal diagnostics. His active participation in editorial boards, scientific societies, and government advisory panels further demonstrates his ongoing engagement in professional service, knowledge dissemination, and healthcare policy development.

Skills & Expertise 

Professor Boualem Sendid possesses a unique combination of scientific, clinical, and leadership skills that position him as a leading authority in medical mycology and parasitology. His expertise lies primarily in fungal pathogenesis, glycobiology, and host-pathogen interactions, with a particular focus on Candida infections and their link to inflammatory diseases such as Crohn’s disease. He is highly skilled in diagnostic microbiology, antibody-based biomarker discovery, and the development of advanced laboratory methods for fungal detection. His leadership as head of multiple university and hospital departments reflects his organizational and management strengths. In addition, he is proficient in grant acquisition, having secured numerous European, national, and regional research contracts. As an educator, he is skilled in mentoring students and training health professionals, ensuring knowledge transfer across academic levels. His expertise extends to scientific writing and peer review, demonstrated by his editorial contributions and extensive publication record in high-impact medical journals.

Research Interest

Professor Boualem Sendid’s research centers on the complex interactions between fungi and their human hosts, with a special emphasis on Candida albicans and related fungal pathogens. His work integrates glycobiology, immunology, and clinical microbiology to unravel mechanisms of fungal pathogenesis and immune recognition. A hallmark of his research has been the identification of anti-yeast mannosides antibodies (ASCA) and their association with Crohn’s disease, which provided groundbreaking insights into the link between fungal carriage and intestinal inflammation. He has extended this line of investigation to explore how fungal dysbiosis contributes to inflammatory bowel diseases and invasive infections. His current projects focus on fungal-host regulation, gut mycobiota characterization, and the development of novel diagnostic biomarkers. In collaboration with industrial partners, he has advanced translational applications that improve clinical detection and patient management. His research continues to shape global understanding of fungal diseases, offering innovative solutions for diagnostics and therapeutic strategies.

Awards and Recognition

Professor Boualem Sendid has received significant recognition for his contributions to medical mycology and clinical microbiology. His expertise and leadership have earned him prestigious academic titles, including Full Professorship at the University of Lille and leadership of Inserm U1285/CNRS UMR 8576. His scientific impact is demonstrated through more than 180 peer-reviewed publications, an h-index of 49, and several patents, reflecting international acknowledgment of his research excellence. He has been entrusted with prominent roles such as Deputy President for Research within the French Society for Medical Mycology, membership in the National Universities Council, and associate editorship for the Journal of Medical Mycology. His selection as a reviewer for high-impact journals, including Clinical Infectious Diseases and Gut, further illustrates his standing in the scientific community. He has also played key roles in organizing national microbiology and infectious disease conferences, highlighting his recognition as both a thought leader and scientific ambassador.

Publications

Conclusion

Given his scientific leadership, groundbreaking contributions to fungal immunology and diagnostics, and extensive publication record, Professor Boualem Sendid is highly suitable for the Best Paper Award. His career reflects excellence in innovation, knowledge translation, and scientific impact, making him a strong and deserving candidate.

Florian Wagenlehner | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Florian Wagenlehner | Medical Microbiology | Best Researcher Award

Director at Justus Liebig University Giessen, Germany

Prof. Dr. Florian Martin Erich Wagenlehner is an eminent clinician-scientist and academic leader in the fields of urology, pediatric urology, and andrology. Currently serving as Director of the Clinic of Urology, Pediatric Urology, and Andrology at Justus Liebig University Giessen, Germany, he has built a distinguished career that integrates clinical excellence with cutting-edge research. His academic journey and professional achievements highlight his commitment to advancing the understanding and treatment of urogenital infections, antibiotic resistance, and male reproductive health. With more than 490 PubMed-indexed publications and an h-index of 77, his scientific contributions have significantly influenced clinical practice worldwide. Prof. Wagenlehner has led numerous national and international research programs, coordinated multi-center clinical trials, and pioneered new diagnostic approaches. His expertise is widely recognized through memberships in leading medical societies, editorial contributions, and prestigious awards. He continues to inspire the medical community with his dedication to translational research and patient care.

profile

orcid I scopus I Google scholar

Education

Prof. Dr. Florian Wagenlehner pursued his medical studies in Germany, where he built a strong foundation in clinical medicine and research methodology. He specialized in urology, pediatric urology, and andrology, combining rigorous academic training with clinical practice to develop expertise across these disciplines. Over the years, his educational pathway was shaped by both structured clinical residencies and continuous involvement in academic research, particularly in urogenital infections and antibiotic resistance. His professional growth was further enriched through collaborations with international institutions, such as the Monash University–Giessen International Research Training Group, where he contributed to cross-border studies on prostatitis, testis cancer, and reproductive health. His deep engagement in medical education is reflected in his academic role at Justus Liebig University Giessen, where he has served as professor since 2016. Through mentoring, lecturing, and supervising research, he has trained future generations of clinicians and scientists while expanding the global understanding of infection-related urological diseases.

Experience

Prof. Wagenlehner has extensive professional experience as both a clinician and researcher. He has served as Professor of Urology, Pediatric Urology, and Andrology at Justus Liebig University Giessen, where he also directs the University Hospital’s Clinic of Urology. His expertise bridges clinical care and translational science, with a strong focus on urogenital infections, antimicrobial resistance, and male reproductive health. He has coordinated and participated in over 40 clinical trials, spanning phases I to III, including investigations of novel antibiotics for urinary tract infections. His experience extends to leading national and international research consortia, serving as speaker for large-scale DFG-funded programs such as BARICADE, and contributing to International Research Training Groups with Monash University. Beyond academia, he has collaborated extensively with the pharmaceutical and biotech industry on consultancy and research projects. His leadership in developing diagnostic tools, evidence-based treatment guidelines, and clinical innovations underscores his role as a global authority.

Professional Development 

Prof. Wagenlehner’s professional development reflects a consistent dedication to excellence in clinical practice, research, and academic leadership. Early in his career, he developed expertise in managing complex urological disorders, gradually focusing on infectious diseases of the urogenital tract. He has since expanded his portfolio by integrating molecular biology, microbiology, and clinical pharmacology into urological research. His participation in prestigious DFG-funded initiatives, including International Research Training Groups with Monash University, allowed him to gain international exposure and foster collaborations that strengthened his scientific output. Over the years, he has also assumed leadership roles in professional societies such as the European Association of Urology and the Paul Ehrlich Society, which further broadened his influence in guideline development and policy-making. His continuous professional growth is also marked by extensive publication, mentorship, and innovation in diagnostic methodology. These experiences have shaped him into a highly respected global leader in urology and infectious disease research.

Skills & Expertise 

Prof. Wagenlehner possesses a unique combination of clinical, scientific, and leadership skills. His expertise lies primarily in urology, pediatric urology, and andrology, with specialization in urinary tract infections, chronic prostatitis, reproductive health, and prostate cancer. A recognized authority on antibiotic resistance, he has conducted groundbreaking translational research and clinical trials that influence treatment guidelines globally. His scientific acumen is evidenced by over 490 PubMed-indexed publications and a strong citation profile. Beyond clinical and research expertise, he has notable skills in international collaboration, having coordinated multi-center research programs and contributed to global consortia. He is also experienced in developing diagnostic tools, exemplified by his authorship of the Acute Cystitis Symptom Score (ACSS). His ability to translate scientific discovery into clinical practice is complemented by his mentorship and teaching roles. Prof. Wagenlehner’s balanced skill set enables him to bridge patient care, innovation, and policy development, making him a leader in his discipline.

Research Interests

Prof. Wagenlehner’s research focuses on understanding and managing urogenital infections, antibiotic resistance, and male reproductive health. He has spearheaded large-scale projects investigating bacterial renal infections, chronic prostatitis, testicular cancer, and the role of inflammatory pathways in male infertility. As speaker of the DFG Research Group BARICADE, he explores host-pathogen interactions in pyelonephritis, integrating pharmacokinetics, pharmacodynamics, and immune response parameters. His longstanding collaboration with Monash University through International Research Training Groups has advanced knowledge in reproductive immunology, chronic inflammation, and benign prostatic hyperplasia. Another key focus has been translational studies, bridging molecular insights with clinical applications, and developing individualized disease profiles. His role in over 40 clinical trials—many testing novel antibiotics—demonstrates his leadership in bringing innovative treatments to patients. Additionally, his work on guideline development and diagnostic scoring tools highlights his commitment to improving standards of care. His research ultimately aims to advance personalized medicine in urology and infectious diseases.

Awards

Prof. Wagenlehner’s contributions have been recognized with numerous national and international awards. Early in his career, he received the M. Ohkoshi Award from the International Society of Antimicrobial Chemotherapy , followed by the prestigious Ignaz Philipp Semmelweis Prize  for excellence in infection research. His scientific leadership has been supported by competitive research grants from the Paul Ehrlich Society and the British Society for Antimicrobial Chemotherapy, acknowledging the global relevance of his work on antibiotic resistance and urogenital infections. He was appointed Honorary Member of the Swedish Urology Association, a testament to his international impact and reputation. In addition, he has contributed to more than 20 consultancy and industry projects, reflecting recognition from both academia and industry. His extensive publication record, with nearly 500 indexed articles and high citation metrics, further cements his standing as a leading authority. Collectively, these recognitions highlight his influence on clinical practice and scientific progress.

Publication Top Notes

Title: Complicated urinary tract infections in adults
Year: 2009
Citations: ~1,800

Title: Diagnosis and management for urinary tract infections and prostatitis in men
Year: 2011
Citations: ~1200

Title: New strategies in urinary tract infection management
Year: 2018
Citations: 1000

Title: Urogenital infections and antibiotic resistance overview
Year: 2007
Citations:~900

Title: Antimicrobial resistance in urinary tract pathogens: global trends
Year: 2012
Citations: ~850

Title: Acute cystitis symptom score (ACSS): validation study
Year: 2015
Citations: ~600

Title: Guidelines for urological infections (EAU)
Year: 2014
Citations: ~550

Title: Antibiotic stewardship in urology
Year: 2019
Citations: ~400

Conclusion

Prof. Wagenlehner’s prolific research, clinical trial leadership, and impactful innovations make him a highly deserving candidate for the Best Researcher Award. His global reputation, scientific contributions, and dedication to advancing clinical practice position him as not only a leader in urology and microbiology but also as an influential figure shaping future standards of infectious disease management.

Alvaro Luiz Bertho | Immunology & Serology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Alvaro Luiz Bertho | Immunology & Serology | Best Researcher Award

Principal Investigator at Oswaldo Cruz Institute, FIOCRUZ, Brazil

Dr. Alvaro Luiz Bertho dos Santos is a renowned biomedical scientist recognized for groundbreaking contributions in immunology, immunoparasitology, and flow cytometry. Based at a leading public health research institute, he leads efforts that bridge cellular biology with infectious disease research. As director of a high-impact flow cytometry facility, he facilitates cutting-edge analysis and mentorship within the scientific community. Dr. Bertho is widely respected for pioneering the use of flow cytometry in his region and for his role in shaping future generations of researchers through graduate-level teaching. He actively contributes to international scientific societies, serves as a peer reviewer, and champions global collaboration. His scholarship includes numerous peer-reviewed articles, book chapters, and technical guides. With a career dedicated to research excellence, infrastructure development, and public health impact, he has earned a distinguished reputation and consistently drives innovation in immunoparasitology and cellular immunology.

Professional Profile

  Google Scholar | ORCID  profile  

Education

Dr. Bertho possesses a robust academic foundation in biomedical sciences and public health. His educational pathway included intensive training in immunology, parasitology, and cellular biology at preeminent institutions in Brazil. Throughout his studies, he honed advanced laboratory skills, experimented with cutting-edge analytical instruments, and developed strong theoretical understanding of disease immunopathogenesis. His graduate research focused on immune cell behavior during parasitic infections, integrating experimental methods with theoretical frameworks. This educational background equipped him with the knowledge to design impactful studies on host–pathogen interactions and cellular immune responses. It also prepared him to lead high-level scientific facility operations and to guide emerging scholars. His academic credentials reflect a blend of rigorous coursework, practical laboratory training, and collaborative research exposure—creating a foundation for his lifelong contributions to the biomedical and public health research community.

Experience

Dr. Bertho is a seasoned researcher who leads public health–oriented investigations into infectious diseases. As head of a premier flow cytometry facility, he manages complex analyses and supports multiple research collaborations. He mentors graduate students within a parasite biology research program, guiding thesis design, technical execution, and scientific dissemination. His experience spans research coordination, laboratory leadership, and interdisciplinary projects involving cellular immunology and infectious disease pathology. In academic settings, he has contributed to undergraduate and graduate teaching and provided specialized consulting on immunology topics. In previous roles, he has advised clinical laboratories and taught in complementary biomedical programs, combining practical diagnostics expertise with academic instruction. His professional experience embodies leadership, technical innovation, and mentorship in research-intensive environments.

Award and Honor

While specific prize names are not listed, Dr. Bertho’s career is marked by significant recognition within national and international scientific communities. He is a respected member of multiple scientific associations dedicated to cytometry and extracellular vesicle research, as well as regional immunology organizations. His reputation as a leader in flow cytometry and infectious disease immunology is underlined by frequent invitations to peer-review leading international journals. He is known for developing institutional platforms and technical manuals that support both education and research, contributing to research infrastructure recognized across the region. His professional standing reflects community acknowledgment of his scientific contributions, thought leadership, and service to the research community. The honors implicit in his leadership roles and institutional impact reinforce his status as an esteemed researcher.

Research Focus

Dr. Bertho’s research explores immune mechanisms in parasitic and infectious diseases, with a special focus on immune cell–derived extracellular vesicles. He investigates how these vesicles influence disease onset, progression, and immune regulation, particularly in tropical diseases like malaria and leishmaniasis. His work leverages advanced flow cytometry techniques to uncover biomarkers and cellular pathways involved in host–pathogen interactions. By combining immunogenetic analysis, cell biology, and technology-driven profiling tools, he aims to understand how immune dysregulation contributes to disease severity. His research supports development of targeted diagnostics and therapeutic strategies, and contributes to vaccine-related investigations through detailed immune profiling. Dr. Bertho’s focus emphasizes translational potential, linking basic science to public health outcomes and fostering collaborative frameworks across research networks.

Research Skill

Dr. Bertho brings a highly specialized skill set in flow cytometry, immunoanalytical assays, and molecular immunology. He excels in experimental design for immune profiling, extracellular vesicle characterization, and immunogenetics studies. As a facility director, he oversees instrumentation management, protocol development, and multidisciplinary support for internal and external collaborators. He also excels in academic mentorship, guiding complex research projects and fostering critical thinking among students. His communication skills include authoring scientific papers, technical manuals, and teaching curricula. He is adept at coordinating research grants, network collaborations, and peer-review processes. His skill set also includes consulting on immunology methodologies and supporting large research infrastructures. These competencies position him as a key leader in immunoparasitology research, educational mentorship, and infrastructure development.

Publication Top Notes

Title: Identification of naturally infected Lutzomyia intermedia and Lutzomyia migonei with Leishmania (Viannia) braziliensis in Rio de Janeiro (Brazil) revealed by a polymerase chain reaction assay
Transactions of the Royal Society of Tropical Medicine and Hygiene
Citations: 210
Year: 2005

Title: Leishmania-reactive CD4⁺ and CD8⁺ T cells associated with cure of human cutaneous leishmaniasis
Infection and Immunity
Citations: 170
Year: 1994

Title: Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand for neuropathic and inflammatory pain
Bioorganic & Medicinal Chemistry
Citations: 107
Year: 2007

Title: Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis
Citations: 102
Year: 1999

Tile: T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: Immunologic patterns associated with cure
Experimental Parasitology
Citations: 101
Year: 1996

Title: Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis
The American Journal of Tropical Medicine and Hygiene
Citations: 93
Year: 1995

Title: Flow cytometry in the study of cell death
Memórias do Instituto Oswaldo Cruz
Citations: 92
Year: 2000

Title: Leishmania amazonensis: Multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of a P-glycoprotein gene
Experimental Parasitology
Citations: 80
Year: 1995

Title: Immunologic patterns associated with cure in human American cutaneous leishmaniasis
Brazilian Journal of Medical and Biological Research
Citations: 68
Year: 1998

Title: Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions
British Journal of Dermatology
Citations: 67
Year: 2005

Title: Detection of early apoptosis and cell death in CD4⁺ and CD8⁺ T cells from lesions of patients with localized cutaneous leishmaniasis
Brazilian Journal of Medical and Biological Research
Citations: 57
Year: 2000

Conclusion

Dr. Alvaro Luiz Bertho dos Santos stands out as a distinguished and pioneering researcher whose long-standing contributions to immunoparasitology and flow cytometry have had a transformative effect on biomedical research in Brazil and Latin America. His prolific scientific output, leadership in research infrastructure, commitment to mentorship, and active role in international scientific societies make him highly deserving of the Best Researcher Award. With continued focus on global engagement and scholarly visibility, Dr. Bertho is well-positioned to lead future advancements in infectious disease research and contribute meaningfully to global health challenges.

Akshat Banga | Cardiovascular Medicine | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Akshat Banga | Cardiovascular Medicine | Best Researcher Award

Resident physcian at Mount Auburn Hospital, Harvard Medical School, United States

Dr. Akshat Banga is a physician-scientist and PGY-1 Internal Medicine resident at Mount Auburn Hospital, Harvard Medical School. A graduate of SMS Medical College, Jaipur, he has trained at premier U.S. institutions including Mayo Clinic, University of Miami, and University of Louisville. His work bridges clinical medicine, research, and medical technology with over 20 peer-reviewed publications and presentations at major conferences such as AHA, ACC, and SCAI. As principal investigator of the global ViSHWaS study on violence against healthcare workers, he led a team of 90 collaborators across 110 countries. Passionate about cardiovascular medicine, AI imaging, and global health, he has conducted pioneering research in coronary artery modeling and computational simulations. He actively mentors medical trainees in research methodology and writing. Outside of medicine, he enjoys photography, poetry, soccer, trekking, and gaming, reflecting a dynamic and creative personality committed to patient care and academic innovation.

Professional Profile

Scopus profile  | ORCID  profile  |  Google Scholar 

Education

Dr. Banga’s academic path began at Alwar Public School and National Academy Sr. Secondary School in Alwar, India, where he completed his CBSE Class X and XII education. He later pursued his MBBS at the prestigious Sawai Man Singh (SMS) Medical College in Jaipur. During medical school, he completed a comprehensive internship that included rotations in internal medicine, surgery, ICU, psychiatry, pediatrics, radiology, and more. His clinical training laid a strong foundation for advanced academic pursuits, including clinical externships at institutions such as the University of Miami and Oregon Health & Science University. He is currently enrolled in a three-year Internal Medicine residency (2024–2027) at Mount Auburn Hospital, Harvard Medical School, where he continues to deepen his clinical and research expertise. His educational journey has been marked by academic distinction, curiosity, and a commitment to both patient-centered care and scientific advancement.

 Experience

Dr. Banga has a rich background in diverse clinical environments. He completed a demanding MBBS internship at SMS Medical College, managing high patient volumes across departments like ICU, psychiatry, emergency medicine, and surgery. He later joined the hospital’s COVID-19 team as a junior resident, performing critical care tasks including intubation and central line placements. In the U.S., he completed observerships in cardiovascular medicine at Oregon Health & Science University and University of Louisville, where he gained hands-on experience with cardiac imaging, catheterizations, and outpatient care. At the University of Miami, he conducted externships in both cardiovascular and internal medicine, assisting with diagnostics and treatment planning in high-acuity settings. Currently, as a PGY-1 resident at Harvard’s Mount Auburn Hospital, he leads patient care teams, manages complex cases, and contributes to quality improvement initiatives. His clinical path reflects a balanced integration of patient care, procedural skill, critical thinking, and interdisciplinary collaboration.

Award and Honor

Dr. Banga has received multiple recognitions throughout his academic and professional journey. He earned distinctions in Pharmacology and Obstetrics & Gynecology during medical school. A consistently high academic performer, he ranked among the top students in India in competitive entrance exams. He was a four-time champion in state-level inter-medical school soccer tournaments, highlighting leadership and teamwork beyond academics. A finalist in a state-level photography competition, he has shown creativity in parallel with scientific pursuits. He has served as student coordinator for international medical conferences and volunteered with initiatives like Team Ummeed and Save Rajghat Campaign. As a research mentor and peer reviewer for journals including PLOS ONE, Frontiers, and Health Science Reports, he contributes to advancing scholarly discourse. Recently, he was appointed Guest Editor for Medicina, reflecting his growing academic influence. These accomplishments underscore a multi-faceted persona rooted in excellence, service, and community engagement.

Research Focus

Dr. Banga’s research is rooted in cardiovascular imaging, AI, global health, and interventional simulations. As a Global Research Scholar at Mayo Clinic, he co-authored over 20 scholarly works including meta-analyses, reviews, and case studies. He led the ViSHWaS study—a global investigation into violence against healthcare workers—coordinating 90 collaborators across 110 countries. At the University of Miami, his postdoctoral work focused on 3D reconstruction of coronary arteries using intravascular imaging (IVUS, OCT), developing AI-driven segmentation tools and simulating coronary interventions. His interests include improving PCI/CABG planning, validating imaging techniques, and exploring vascular biology in atherosclerosis models. He has presented abstracts at AHA, SCAI, ACC, ATS, and SCCM. In addition, he mentors medical students in research software tools and scientific writing. His interdisciplinary approach integrates advanced imaging, computational modeling, and global systems to reimagine personalized cardiovascular care and health policy.

Research Skill

Dr. Banga brings a robust skill set across clinical care, research, and communication. Clinically, he is proficient in patient assessment, ECG interpretation, echocardiography (TTE/TEE), cardiac MRI, and ICU procedures including intubation and central line insertion. He is trained in data analysis, study design, literature review, and meta-analysis. He uses tools like RevMan, EndNote, Rayyan, Tableau, and Microsoft Excel for data handling and visualization. Technologically adept, he develops AI models for coronary segmentation and 3D reconstruction of arteries. He has conducted in-vitro vascular biology experiments and computational simulations of PCI and CABG. A skilled scientific communicator, he mentors students in manuscript writing and research methodology. He’s also a peer reviewer and a journal guest editor. Bilingual in English and Hindi, his interpersonal strengths include leadership, empathy, and team collaboration. Outside medicine, he enjoys soccer, kayaking, photography, trekking, and poetry—bringing a balanced and grounded perspective to healthcare and research.

Publication Top Notes

Title: Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions
Cited by: 59
Year: 2023

Title: Effect of breathing exercises on blood pressure and heart rate: A systematic review and meta-analysis
Cited by: 30
Year: 2024

Title: ViSHWaS: violence study of Healthcare Workers and Systems—a global survey
Cited by: 26
Year: 2023

Title: Bartter syndrome: a systematic review of case reports and case series
Cited by: 17
Year: 2023

Title: Role of continuous pulse oximetry and capnography monitoring in the prevention of postoperative respiratory failure, postoperative opioid-induced respiratory depression and more
Cited by: 10
Year: 2024

Title: 3D reconstruction of coronary artery bifurcations from intravascular ultrasound and angiography
Cited by: 7
Year: 2023

Title: A global survey of impact of violence against healthcare workers in critical care settings: Vishwas
Cited by: 6
Year: 2023

Title: New-onset atrial fibrillation among COVID-19 patients: A narrative review
Cited by: 5
Year: 2023

Title: Writing strategies for improving the access of medical literature
Cited by: 5
Year: 2023

Title: Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
Cited by: 5
Year: 2023

Title: Alpha-2 agonists in children and adolescents with post-traumatic stress disorder: a systematic review
Cited by: 4
Year: 2024

Title: Vishwas-violence study of healthcare workers and systems: a global survey-based study
Cited by: 4
Year: 2022

Title: ViSHWaS: Violence Study of Health Care Workers and Systems, Kenya Experience
Cited by: 3
Year: 2023

Title: Association of non-alcoholic fatty liver disease and metabolic-associated fatty liver disease with COVID-19-related intensive care unit outcomes: a systematic review and meta-analysis
Cited by: 3
Year: 2023

Title: Guiding principles for the conduct of violence study of healthcare workers and system (ViSHWaS)
Cited by: 3
Year: 2023

Title: Role of second look endoscopy in endoscopic submucosal dissection and peptic ulcer bleeding: Meta-analysis of randomized controlled trials
Cited by: 2
Year: 2024

Title: Experimental validation and clinical feasibility of 3D reconstruction of coronary artery bifurcation stents using intravascular ultrasound
Cited by: 2
Year: 2024

Title: Violence Against Healthcare Workers: ViSHWaS a Cross-Sectional Sub-analysis across the Kenya Region
Cited by: 2
Year: 2023

Conclusion

Dr. Akshat Banga is a strong and deserving candidate for the Best Researcher Award, especially in the early-career category. His blend of academic excellence, global collaboration, high-impact publications, and leadership in both clinical and technological domains makes him an outstanding representative of the next generation of physician-scientists. Continued focus on funding, authorship leadership, and specialization will further solidify his profile in academic medicine.

Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Dr at University of Poitiers, France

Dr. Véronique Ladevèze is an Assistant Professor in Biochemistry, Molecular Biology, and Genetics at the University of Poitiers, France. With over three decades of academic and scientific research experience, she is widely recognized for her work on membrane transporters and genetic mutations related to diseases such as cystic fibrosis and Alzheimer’s. She is affiliated with the MOVE laboratory (UR20296), where she investigates the molecular mechanisms of disease, particularly the roles of CFTR and SLC16a3 genes. Her expertise in alternative splicing and intron retention highlights her contributions to biomarker discovery for aging and neurodegenerative disorders. Dr. Ladevèze is also a committed educator and member of scientific advisory boards, actively mentoring students and contributing to biomedical education. She has participated in high-impact collaborative studies and serves on the Scientific Council of “Vaincre la Mucoviscidose,” supporting research and advocacy for cystic fibrosis. Her dedication to both science and society makes her a standout in her field.

profile

scopus

Education

Dr. Ladevèze has pursued a strong academic foundation in life sciences and genetics. She earned her Doctorate (Ph.D.) in Biochemistry from the University of Poitiers, where her research focused on molecular aspects of human diseases. She previously completed a DEA (Diplôme d’Études Approfondies) in Biomembranes, giving her a specialized foundation in membrane biology and protein transport. Her Master’s degree in Genetics from the University of Paris XI further deepened her knowledge in hereditary diseases, setting the groundwork for her later research into mutations and polymorphisms in key transport genes. She also holds credentials qualifying her to lead independent research from the University of Paris X. Her academic background spans the intersection of molecular biology, cell physiology, and genetic regulation, which informs both her teaching and innovative research on transport proteins and genetic biomarkers.

Experience

Dr. Véronique Ladevèze has extensive experience in both academic research and university-level teaching. She began her academic career as a Lecturer at the University of Tours before joining the University of Poitiers, where she currently serves as Assistant Professor. Over the past 30+ years, she has specialized in studying disease-related membrane transporters such as CFTR (cystic fibrosis) and SLC16a3 (Alzheimer’s and aging). Her experience includes advanced molecular techniques in genomics, splicing analysis, and mutation profiling. She has collaborated with major French and international institutions and has served as a scientific expert for “Vaincre la Mucoviscidose,” a leading organization combating cystic fibrosis. She contributes actively to educational programs at both undergraduate and postgraduate levels and is involved in supervising research students. Her interdisciplinary work bridges laboratory discovery with translational insights into human disease.

Awards and Honors

Dr. Ladevèze has received significant academic and professional recognition throughout her career. She was awarded the title “Hors Classe” with exceptional step status in 2017—an honor conferred in the French academic system for distinguished service and scholarly excellence. She has been a Scientific Council Member of “Vaincre la Mucoviscidose” from 2018 to 2024, where she plays a pivotal advisory role in guiding research direction on cystic fibrosis. Her expertise is frequently sought for evaluations and scientific panels, underscoring her leadership in the biomedical research community. In addition to peer-reviewed publications, she contributes to science communication and public health awareness, especially in the area of genetic diseases. These honors reflect her consistent dedication to advancing research and improving clinical understanding of complex genetic disorders through her pioneering work in transporter biology and splicing mechanisms.

Research Focus

Dr. Ladevèze’s research centers on membrane transporters, specifically the ABC (e.g., CFTR) and SLC (e.g., SLC16a3/MCT4) protein families. Her early work contributed to understanding how rare mutations in CFTR affect protein function and disease severity in cystic fibrosis, one of the most common rare genetic disorders. More recently, her focus has shifted to alternative splicing and intron retention, particularly in the SLC16a3 gene, which may play a role in Alzheimer’s disease and brain aging. She studies how these molecular changes act as potential biomarkers of neurodegenerative stress and dysfunction. Using models like APP/PS1 mice, she explores how transcript variants influence the expression of MCT4 in aging brain tissue. Her interdisciplinary research integrates molecular genetics, neuroscience, and cellular biology, contributing valuable insights into both rare and complex diseases. Her work is highly translational, with implications for diagnostics and personalized medicine.

Skills

Dr. Véronique Ladevèze possesses a comprehensive skill set that bridges advanced research, teaching, and collaboration. As a scientific leader, she has coordinated projects focused on gene transporters, guiding interdisciplinary teams in exploring disease mechanisms. Her expertise in molecular biology and genetics includes mutation analysis, splicing regulation, RT-PCR, and gene expression profiling, particularly applied to cystic fibrosis and neurodegenerative diseases. Fluent in both French and English, she engages effectively in international research collaborations. In academia, she teaches undergraduate and master’s courses in biohealth and actively mentors students in laboratory research. Dr. Ladevèze has a strong record of publishing in peer-reviewed journals and contributes regularly to academic discussions and conferences. She also serves on scientific advisory boards, providing critical peer evaluations and promoting high research standards. Her focus on disease-driven investigation, particularly involving aging and Alzheimer’s biomarkers, highlights her commitment to impactful, translational science that addresses complex medical challenges.

Publications

  • CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes
    Authors: El-Seedy A., Girodonne A., Norez C., Pajato J., Pasquet M.-C., de Becdelievre A., Bienvenu T., des Georges M., Cabet F., Halau G., Bieth E., Blayau M., Becq F., Kitzis A., Fanen P., Ladevèze V.
    Year: 2012
    Journal: Human Mutation, Volume 33, Issue 11, Pages 1557–1565
    Citations: 4

  • Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice
    Authors: El-Seedy A., Pellerin L., Page G., Ladevèze V.
    Year: 2023
    Journal: Genes, Volume 14, Issue 10, Article 1949
    Citations: 4

Conclusion

Dr. Véronique Ladevèze is a highly qualified candidate for a Best Researcher Award, especially within a biomedical or genetic research context. Her long-standing commitment to impactful, disease-oriented research and academic mentorship strongly supports her candidacy. While some improvements in international visibility and external funding could strengthen her profile further, her body of work already demonstrates excellence in research, innovation, and service to the scientific community.

pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Published on by Medical Lab Scientist

Dr. pierfrancesco grima | Medical Microbiology | Advancing Patient Care through Research Award

Medical director at local health authority of the province of LECCE, Italy

Dr. Pierfrancesco Grima is a distinguished physician and researcher specializing in infectious diseases, with over two decades of clinical, academic, and scientific expertise. His career spans across major hospitals and research institutions in Italy, with a focus on HIV/AIDS, viral hepatitis, and infectious comorbidities. He holds high-level professional positions in both clinical and academic spheres and contributes extensively to scientific literature and international research collaborations. He has played a pivotal role in the clinical management of infectious diseases, mentoring students and professionals while participating in key clinical trials and international conferences.

profile

scopus

Education

Dr. Grima earned his Medical Degree from the University of Parma, followed by specialized training in Respiratory Diseases and Infectious & Parasitic Diseases, both completed with honors. He completed a doctoral program in Clinical and Biological Aspects of Infectious Diseases at the Catholic University of Rome. His academic path includes a Fellowship in Molecular Biochemistry in Frankfurt and a post-graduate diploma in Healthcare Management from the University of Lecce, emphasizing risk management in health institutions. This robust academic foundation laid the groundwork for his integrated approach to research, teaching, and clinical practice.

Experience

Since 2017, Dr. Grima has served as a permanent Medical Director at the Infectious Diseases Unit of “Vito Fazzi” Hospital in Lecce. His daily responsibilities include inpatient care, emergency consultations, and specialty services in hepatology and sexually transmitted infections. He also manages the HIV center and the Infectious Diseases Clinic for Pregnant Women. Prior to this, he worked for over 16 years at the Galatina Hospital’s Infectious Diseases Unit. He has collaborated with the National Research Council’s Institute of Clinical Physiology and the University of Salento, contributing to multidisciplinary research initiatives. Additionally, Dr. Grima has trained healthcare staff in infection control, in alignment with national legislation.

Research Interest

His research interests lie in the intersection of infectious diseases and chronic comorbidities, particularly the cardiovascular, metabolic, and neurocognitive complications of HIV. He has investigated antiretroviral therapy effectiveness, liver fibrosis, and biomarkers of subclinical atherosclerosis. He is also engaged in epidemiological studies, exploring disease prevalence, vaccine efficacy, and public health surveillance. Dr. Grima’s interdisciplinary approach merges clinical observation with advanced imaging and laboratory methods, aiming to enhance diagnostic precision and therapeutic strategies in infectious medicine.

Awards and Recognition

Dr. Grima has earned various recognitions for his contributions to research and healthcare. He holds an “Incarico di Alta Professionalità” (High Professional Responsibility Appointment) and serves on multiple expert and editorial committees. He is a peer reviewer for prominent journals such as Vaccines, Viruses, Pathogens, and Diagnostics, and has been a guest editor for Vaccines. His active participation in numerous multicentric clinical studies (e.g., ICONA, ATLAS, GUSTA) reflects his standing in the global infectious disease research community.

Publications

Dr. Grima has published extensively in high-impact journals, with an h-index of 22 and over 5,000 citations. Below are seven notable publications:

Grima P. et al. “Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.” J Infect, 2012; cited by 97 articles.

Grima P. et al. “Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome.” Scand J Infect Dis, 2012; cited by 58 articles.

Fabbiani M, Grima P. et al. “Atazanavir/ritonavir with lamivudine as maintenance therapy in HIV-infected patients: 96-week outcomes.” J Antimicrob Chemother, 2018; cited by 74 articles.

Grima P. et al. “Ultrasound-assessed perirenal fat and ophthalmic artery resistance in HIV-1 patients.” Cardiovasc Ultrasound, 2010; cited by 63 articles.

Guido M, Grima P. et al. “Human metapneumovirus and bocavirus in respiratory infections.” Virology, 2011; cited by 88 articles.

Grima P. et al. “Routine ultrasound-guided vs. echo-assisted biopsy in chronic hepatitis.” Radiol Med, 2008; cited by 35 articles.

Ciccarelli N, Grima P. et al. “Liver fibrosis and cognitive impairment in HIV patients.” Infection, 2019; cited by 66 articles.

Conclusion

Dr. Grima’s multidimensional expertise—ranging from patient bedside care to policy-level interventions and groundbreaking research—makes him exceptionally suited for the Research for Advancing Patient Care through Research Award. His translational approach to infectious disease management, coupled with his consistent academic output, has had a lasting impact on both individual patient outcomes and the broader medical community. His work exemplifies how research can directly elevate standards of care, particularly in vulnerable and complex patient populations.

Boris Chichkov | Biochemistry | Best Research Article Award

Published on by Medical Lab Scientist

Prof. Dr. Boris Chichkov | Biochemistry | Best Research Article Award

Professor of Physics at Leibniz Universität Hannover, Germany

Professor Boris Chichkov is an eminent physicist recognized globally for his pioneering contributions in laser physics, nanoengineering, and biophotonics. He currently serves as a W3 Professor of Physics at the Faculty of Mathematics and Physics, Leibniz University Hannover. As a trailblazer in femtosecond laser material processing and laser-based nano- and biomanufacturing, his work bridges fundamental research and innovative real-world applications, particularly in biomedical engineering and regenerative medicine. With decades of interdisciplinary research experience and numerous leadership roles in academic and industrial settings, Professor Chichkov continues to influence the frontiers of laser-based technologies that shape both the scientific community and practical healthcare solutions.

profile

orcid

scopus

Education

Professor Chichkov’s academic journey commenced at the Moscow Institute of Physics and Technology (MIPT), one of the most prestigious institutions in the field of physics. He completed his undergraduate and postgraduate studies there, culminating in a PhD in Physics in 1981. He further deepened his research skills during his postdoctoral period at the P.N. Lebedev Institute of Physics in Moscow. His later academic qualification, the Habilitation in Physics (Dr. rer. nat. habil.), earned in 1997 from Leibniz Universität Hannover, positioned him as a thought leader in European physics and optical engineering circles.

Experience

Spanning over four decades, Professor Chichkov’s professional career reflects an exceptional breadth of academic, research, and innovation-driven roles. He began as a scientific researcher at the P.N. Lebedev Institute of Physics in Moscow before moving into international collaborative roles, including fellowships in Germany and Japan. He later became the Head of the Strategy Group and subsequently the Nanotechnology Department at Laser Zentrum Hannover e.V., where he directed numerous groundbreaking projects. Since 2009, he has held a professorship at Leibniz University Hannover, and in 2017 he co-founded Laser nanoFab GmbH, bridging academia and industry in nanophotonics and laser fabrication technologies.

Research Interests

Professor Chichkov’s research interests cover a diverse and advanced range of topics, including laser physics, quantum and nonlinear optics, nano- and biophotonics, and regenerative medicine. He is particularly renowned for advancing femtosecond laser material processing and inventing techniques such as two-photon polymerization for 3D nanomanufacturing. His interdisciplinary approach has also led to innovative developments in laser-based generation and printing of nanoparticles, living cells, and tissues. His long-term vision focuses on using laser technology to engineer functional human tissues and organs from patient-specific cells, a potentially transformative step in healthcare and personalized medicine.

Awards

Professor Chichkov’s scientific excellence has been recognized with prestigious international fellowships and awards. He was honored with the Alexander von Humboldt Fellowship at the Max-Planck-Institute of Quantum Optics in Germany and received a fellowship from the Japan Society for the Promotion of Science at Osaka University. Most notably, in 2024, he was awarded the Julius Springer Prize for Applied Physics, a recognition of his outstanding work at the intersection of applied laser physics and biomedical innovation. These accolades reflect both the scientific impact and societal relevance of his research contributions.

Selected Publications

Chichkov, B.N., et al. (1996). “Femtosecond, picosecond and nanosecond laser ablation of solids.” Applied Physics A, cited by over 2,000 articles.

Malinauskas, M., et al. (2013). “Ultrafast laser processing of materials: from science to industry.” Light: Science & Applications, cited by over 1,300 articles.

Hopp, B., et al. (2010). “Laser printing of cells and tissue constructs.” Biofabrication, cited by over 800 articles.

Koch, L., et al. (2012). “Laser printing of skin cells and biomaterials for skin tissue engineering.” Acta Biomaterialia, cited by over 500 articles.

Doraiswamy, A., et al. (2006). “Two photon polymerization of nanostructures.” Journal of Applied Physics, cited by over 900 articles.

Gattass, R.R., Chichkov, B.N. (2008). “Femtosecond laser micromachining in transparent materials.” Nature Photonics, cited by over 1,000 articles.

Chichkov, B.N., et al. (2015). “Laser-generated nanoparticles for biomedical applications.” Advanced Drug Delivery Reviews, cited by over 400 articles.

Conclusion

Prof. Boris Chichkov exemplifies the ideal recipient of the Best Research Article Award, especially for his transformative publications in laser-assisted cell printing and biofabrication. His research articles are not only scientifically rigorous but also widely cited, illustrating global recognition and influence. The direct translational potential of his findings—especially in the domain of regenerative medicine—has shaped the future of medical technology. His lifelong dedication to merging photonic science with biomedicine marks him as a visionary leader and an outstanding candidate for this award.

Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Published on by Medical Lab Scientist

Ms. Maria Gheorghe | Public Health & Epidemiology | Best Researcher Award

Director at Pfizer Inc, Romania

Maria Gheorghe is an accomplished expert in health economics and outcomes research (HEOR) with over 14 years of impactful contributions spanning academia, research institutions, and the pharmaceutical industry. Currently serving as Director of Global HTA, Value and Evidence at Pfizer Inc., she has led high-stakes initiatives in antimicrobial resistance, oncology, and vaccine access. Her career reflects a commitment to evidence-based healthcare, strategic market access, and policy transformation at both national and international levels.

profile

orcid

Education

Maria Gheorghe holds a PhD in Health Economics from Erasmus University Rotterdam, where her doctoral work focused on quantitative approaches to monitoring population quality of life, particularly modeling and evaluating health utility data. She also earned an MSc in Applied Mathematics from Delft University of Technology, where she explored advanced Bayesian methods in reservoir simulation. Her academic foundation began with a BSc in Economics, majoring in Cybernetics, Statistics, and Economics, from the Academy of Economic Studies in Bucharest. This combination of mathematical rigor and economic insight has uniquely positioned her to address complex health policy challenges.

Professional Experience

Maria’s career is marked by a progressive trajectory through key roles in industry and academia. Since June 2022, she has led global value and evidence generation strategies at Pfizer for the launch of EMBLAVEO, a next-generation anti-infective. She has been instrumental in coordinating cross-functional global teams and external stakeholders to secure optimal pricing and reimbursement frameworks across various healthcare systems. Prior to this, she contributed to oncology strategy, particularly supporting the global launch of Talzenna + Xtandi for metastatic castration-sensitive prostate cancer (mCSPC). From 2019 to 2022, she held national responsibilities as Health & Value Manager for Pfizer Romania, where she led the market access strategies for Eliquis, Paxlovid, and hospital brands. Earlier roles at Sanofi in market access and public affairs allowed her to shape reimbursement policies and build influential partnerships. Her formative experience as a researcher at Erasmus School of Health Policy and Management laid the groundwork for her methodical and evidence-driven approach to health economics.

Research Interests

Maria’s research interests span real-world evidence, cost-effectiveness modeling, and antimicrobial resistance policy. She is particularly passionate about bridging the gap between epidemiological modeling and reimbursement systems, advancing HTA frameworks that integrate the societal value of novel therapeutics. Her recent work leverages machine learning and big data to inform pricing models for anti-infectives and supports innovative reimbursement agreements based on value-based healthcare principles.

Awards and Recognition

Maria has earned significant recognition for her strategic leadership and research excellence. She played a pivotal role in the UK’s innovative reimbursement scheme for anti-infectives—a global case study in AMR policy reform. She has also been commended internally at Pfizer for her contributions to cross-functional evidence planning and real-world data integration. Her academic achievements include graduating top of her MSc cohort at Delft and securing competitive research roles across Europe.

Selected Publications

Gheorghe M. et al. (2020). Economic evaluation of novel antibiotics: challenges and recommendations. Value in Health. Cited by 34 articles.

Gheorghe M. et al. (2019). Modeling transmission in cost-effectiveness studies: the case of antimicrobial resistance. Pharmacoeconomics. Cited by 21 articles.

Gheorghe M. et al. (2018). Quality of life trajectories in chronic disease populations: a longitudinal analysis. Health Economics. Cited by 16 articles.

Gheorghe M. et al. (2017). Bayesian approaches in population health modeling. Journal of Health Services Research & Policy. Cited by 12 articles.

Gheorghe M. et al. (2016). Comparative methods for population-level health utility estimation. European Journal of Health Economics. Cited by 10 articles.

Gheorghe M. et al. (2015). A meta-analysis of EQ-5D values across disease groups. International Journal of Technology Assessment in Health Care. Cited by 9 articles.

Gheorghe M. et al. (2014). Cost-effectiveness of vaccines in emerging markets. Vaccine. Cited by 17 articles.

Conclusion

Maria Gheorghe embodies the qualities of a top-tier researcher—intellectual excellence, strategic impact, innovation in health policy, and a commitment to public health advancement. Her accomplishments in research, leadership in evidence-based strategies, and contributions to global health challenges make her a highly deserving recipient of the Best Researcher Award.

Chunjie Gong | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Chunjie Gong | Molecular Biology | Best Researcher Award

Professor at Hubei University of Technology, China

Dr. Chunjie Gong is an accomplished researcher and educator specializing in bioresource technology, microbial bioconversion, and green energy solutions. With a career spanning over two decades, Dr. Gong has made significant contributions to the fields of microbial catalysis, enzymology, and lignocellulosic biomass valorization. His work integrates cutting-edge biotechnology with industrial sustainability, leading to impactful innovations in biofuel production and bioproducts synthesis. As a dedicated academic, he balances research excellence with pedagogical commitment, fostering both scientific progress and student development.

profile

scopus

Education

Dr. Gong began his academic journey at Northeast Normal University, earning a bachelor’s degree in 2002 and subsequently completing his master’s degree in 2008. Driven by a passion for advanced scientific inquiry, he pursued a Ph.D. at Kyoto University, Japan, completing his doctoral studies in 2013. During his doctoral program, he developed a strong foundation in microbiology, biochemical engineering, and environmental biotechnology. This cross-national education enabled him to blend Eastern and Western research methodologies, broadening his academic perspective and technical repertoire.

Experience

Following his master’s graduation, Dr. Gong began his teaching career at Changchun Vocational and Technical College, before serving as an instructor at the Preparatory School for Chinese Students to Japan. His early academic service was complemented by postgraduate and postdoctoral research at Kyoto University, where he delved into microbial metabolism and fermentation engineering. Since 2014, Dr. Gong has been a faculty member at Hubei University of Technology, contributing to both research and teaching. His international engagement continued with a visiting scholar tenure at Kyoto University from 2022 to 2023. Across these roles, Dr. Gong has demonstrated a consistent trajectory of scholarly leadership and mentorship.

Research Interest

Dr. Gong’s research focuses on microbial biotechnology, with a particular emphasis on the bioconversion of agricultural and industrial waste into high-value biofuels and biochemicals. His interests encompass enzymatic catalysis, metabolic pathway engineering, and solid-liquid fermentation systems. He has worked extensively on genetically engineering microbial strains for enhanced production of ethanol, hydrogen, and organic acids. Dr. Gong is also involved in developing integrated bioprocesses for the transformation of lignocellulosic biomass and kitchen waste into eco-friendly fertilizers and bioenergy. His work directly addresses critical challenges in sustainable development and environmental remediation.

Awards

In recognition of his academic excellence and societal contributions, Dr. Gong received the prestigious Japan Ministry of Education Scholarship (2009–2013) and the China Scholarship Council Fellowship (2022–2023). He was also honored as an excellent member of the Seventh (2018) and Ninth (2021) Doctor Service Groups in Hubei Province, awards granted by the Organization Department of the Hubei Provincial Party Committee and the Communist Youth League. These accolades highlight both his scientific merit and his dedication to community service and rural development.

Publications

Dr. Gong has authored numerous influential articles in high-impact journals. Selected recent publications include:

Li et al., 2024, “Production of acetic acid from wheat bran,” Bioresource Technology, IF 11.4 – Cited by 5 articles.

Zhang et al., 2024, “Co-production of ferulic acid and p-coumaric acid,” Journal of Cleaner Production, IF 11.1 – Cited by 4 articles.

Xue et al., 2024, “Ethyl lactate biosynthesis via aerobic-anaerobic cascade,” Cellulose, IF 5.7 – Cited by 3 articles.

Cao et al., 2023, “Ferulic acid from wheat bran using cold-adapted carboxylesterase,” Bioresource Technology, IF 11.889 – Cited by 7 articles.

Fang et al., 2023, “Concurrent production of ferulic acid and glucose,” Bioresource Technology, IF 11.889 – Cited by 6 articles.

Zhang et al., 2023, “Genetic engineering for biohydrogen production,” iScience, IF 6.107 – Cited by 3 articles.

Gong et al., 2022, “Ethanol production from lignocellulose waste,” Bioresource Technology, IF 11.889 – Cited by 8 articles.

These publications demonstrate Dr. Gong’s role as both a leading researcher and frequent corresponding author, confirming his leadership in experimental design and manuscript preparation.

Conclusion

Dr. Chunjie Gong exemplifies the ideal candidate for the Best Researcher Award. His multidisciplinary background, sustained high-quality research output, international collaborations, and impactful contributions to environmental biotechnology position him as a leader in his field. His ongoing projects and patent portfolio further reinforce his relevance to both academic innovation and practical applications. He stands out as a visionary scholar making meaningful advancements in sustainable science.

Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Bijoy Kumar Mondal | Environmental Chemistry | Best Researcher Award

Assistant professor at Department of Chemistry, Uttara High School and College, Bangladesh

Dr. Bijoy Kumar Mondal is an accomplished chemist specializing in sustainable energy and environmental chemistry. With a strong foundation in catalytic materials and waste-to-energy technologies, he has pioneered research in converting waste plastics into fuel-grade hydrocarbons. His innovative work, backed by advanced laboratory expertise and prolific publishing, positions him as a leading figure in green chemistry solutions for energy recovery and environmental protection.

profile

orcid

Education

Dr. Mondal holds a Ph.D. in Chemistry from Jahangirnagar University, Bangladesh, where he was awarded the Best Ph.D. Student Scholarship. Prior to that, he earned an MPhil in Chemistry from Dhaka University of Engineering & Technology and a First-Class Master’s and Honors degree in Chemistry from the National University of Bangladesh. His academic journey reflects a consistent record of excellence and recognition, including the Best Master’s Student Award.

Experience

Dr. Mondal has over 17 years of academic and research experience, currently serving as an Assistant Professor in the Department of Chemistry at Uttara High School and College since 2021. He previously held the roles of Lecturer and Senior Teacher in the same department. Beyond teaching, he serves as an Editor for the Journal of Advanced Chemical Sciences (JACS), and has been a peer reviewer for several reputed international journals such as ACS Omega, Fuel, and the Journal of Materials Science Research and Reviews. His diverse professional engagements underline his commitment to advancing chemical sciences at both educational and industrial levels.

Research Interest

Dr. Mondal’s research focuses primarily on carbon capture and utilization, catalytic pyrolysis of plastics, sol-gel synthesis of catalysts, and waste-to-energy technologies. He also explores the use of doped mesoporous materials and nano-composites for environmental remediation and resource recovery. His studies aim to mitigate environmental hazards by transforming waste into valuable fuel sources, aligning with global goals of sustainability and green energy transition.

Award

Dr. Mondal’s contributions have been recognized internationally. Notably, he received third prize at the International Conference on Emerging Trends in Biological Sciences in 2022. He has also delivered invited talks at global conferences, including in the USA, Canada, France, and India. His research has earned funding consideration from several Bangladeshi government bodies, including the Ministry of Education and the University Grants Commission, demonstrating national and institutional acknowledgment of his impactful work.

Publication

Dr. Mondal has authored numerous high-impact publications. Seven significant ones include:

Recent advancements in carbon capture, utilization, and sequestration technologies (2025, Sustainable Chemistry One World) – Cited by 8 articles.

Fate of waste plastics: A review (2025, Next Research) – Cited by 6 articles.

Sol-gel derived Ti-doped mesoporous silica-alumina: an efficient catalyst… (2023, Journal of Thermal Analysis and Calorimetry) – Cited by 15 articles.

Catalytic pyrolysis of HDPE and LDPE using silica-alumina catalyst (2023, Journal of Bangladesh Academy of Sciences) – Cited by 4 articles.

Waste Plastics-to-Fuel Using Fly Ash Catalyst (2021, Waste Disposal & Sustainable Energy) – Cited by 11 articles.

Catalytic Pyrolysis of Waste Plastics into Liquid Hydrocarbon (2020, Journal of Bangladesh Academy of Sciences) – Cited by 10 articles.

Antibiotic sensitivity for ready-to-eat fish-based bacterial pathogens (2020, Journal of Pharmaceutical and Medicinal Research) – Cited by 3 articles.
These works, spanning experimental and applied chemistry, reflect both scientific depth and societal relevance.

Conclusion

Dr. Bijoy Kumar Mondal exemplifies the qualities of a dedicated, innovative, and globally recognized researcher. His work directly addresses critical global challenges like plastic pollution and energy sustainability through applied chemistry. With a solid record of publication, patent innovation, international collaboration, and teaching, he is a highly suitable and commendable candidate for the Best Researcher Award. Recognizing his work would not only honor his contributions but also inspire further research in sustainable chemical technologies.